Evidence map›Paper›PMID 26773018›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2016

Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation.

YingYing He, Nathan T Lawlor, David S Newburg

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

YingYing HeProgram in Glycobiology, Department of Biology, Boston College, Chestnut Hill, MA.
Nathan T LawlorProgram in Glycobiology, Department of Biology, Boston College, Chestnut Hill, MA.
David S NewburgProgram in Glycobiology, Department of Biology, Boston College, Chestnut Hill, MA david.newburg@bc.edu.ORCID http://orcid.org/0000-0001-6042-7303
Boston College · US

Funding

VIRAL GASTROENTERITIS PATHOGENSP01HD013021 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI RUIZ-PALACIOS, GUILLERMO · 1985 to 2013
$15.0M
Novel broad spectrum therapeutic glycans against Category B pathogensU01AI075563 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI NEWBURG, DAVID S. · 2007 to 2011
$4.5M
Novel genetic and salivary glycan biomarkers for risk of NEC in ELBW infants.R01HD059140 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI MORROW, ARDYTHE L · 2009 to 2013
$3.3M
NIAID NIH HHS U01AI075563NICHD NIH HHS P01HD013021NICHD NIH HHS R01HD059140
6 · The paper itself

Abstract

Toll-like receptor (TLR) signaling is central to innate immunity. Aberrant expression of TLRs is found in neonatal inflammatory diseases. Several bioactive components of human milk modulate TLR expression and signaling pathways, including soluble toll-like receptors (sTLRs), soluble cluster of differentiation (sCD) 14, glycoproteins, small peptides, and oligosaccharides. Some milk components, such as sialyl (α2,3) lactose and lacto-N-fucopentaose III, are reported to increase TLR signaling; under some circumstances this might contribute toward immunologic balance. Human milk on the whole is strongly anti-inflammatory, and contains abundant components that depress TLR signaling pathways: sTLR2 and sCD14 inhibit TLR2 signaling; sCD14, lactadherin, lactoferrin, and 2'-fucosyllactose attenuate TLR4 signaling; 3'-galactosyllactose inhibits TLR3 signaling, and β-defensin 2 inhibits TLR7 signaling. Feeding human milk to neonates decreases their risk of sepsis and necrotizing enterocolitis. Thus, the TLR regulatory components found in human milk hold promise as benign oral prophylactic and therapeutic treatments for the many gastrointestinal inflammatory disorders mediated by abnormal TLR signaling.

Indexed as

Breast FeedingEnterocolitis, NecrotizingHumansInfant, NewbornInflammationInflammation MediatorsMilk, HumanSepsisToll-Like ReceptorsInflammation MediatorsToll-Like Receptorsglycanshuman milkimmune functioninflammationtoll like receptors

Identifiers

PMID26773018
PMCPMC4717889
OpenAlexW2297172193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.